first statins. they have gone off patent. you need generics to have innovation. >> there is a move about whether the copays, merck and glaxo said they will hold off on affordable act copays. can you tell us about that? >> those stories have to do in essence of whether we provide coupons for pharmaceuticals for people who have copays who are struggling to pay. we want to help people whether it's the patient assistance program or the copay assistance. right now there is a lack of clarity around the law and whether or not those programs under the affordable care act are legal and appropriate. we are going to try to cocome to a conclusion. that's what that is about. getting the clarity we need. >> we're don't know if it's